Compare MSCI & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MSCI | A |
|---|---|---|
| Founded | 1998 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.3B | 39.8B |
| IPO Year | 2007 | 1999 |
| Metric | MSCI | A |
|---|---|---|
| Price | $574.95 | $121.07 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 16 |
| Target Price | ★ $658.50 | $161.06 |
| AVG Volume (30 Days) | 772.0K | ★ 2.3M |
| Earning Date | 04-29-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.45% | 0.86% |
| EPS Growth | ★ 11.67 | 3.16 |
| EPS | ★ 15.69 | 1.07 |
| Revenue | $1,274,172,000.00 | ★ $4,472,000,000.00 |
| Revenue This Year | $12.52 | $8.42 |
| Revenue Next Year | $8.53 | $6.12 |
| P/E Ratio | $36.08 | ★ $26.01 |
| Revenue Growth | N/A | ★ 6.43 |
| 52 Week Low | $486.74 | $96.43 |
| 52 Week High | $626.28 | $160.27 |
| Indicator | MSCI | A |
|---|---|---|
| Relative Strength Index (RSI) | 55.72 | 37.02 |
| Support Level | $539.82 | $109.69 |
| Resistance Level | $581.50 | $123.79 |
| Average True Range (ATR) | 15.84 | 3.69 |
| MACD | 4.98 | -0.12 |
| Stochastic Oscillator | 99.09 | 45.21 |
MSCI has described its mission as enabling investors to build better portfolios for a better world. MSCI's largest and most profitable segment is its index segment, where it provides benchmarking to asset managers and asset owners. MSCI boasts over $18 trillion in benchmarked assets, including over $2.3 trillion in ETF assets linked to MSCI indexes. The MSCI analytics segment provides portfolio management and risk management analytics software to asset managers and asset owners. In its sustainability and climate segment, MSCI provides ESG data to the investment industry. In private assets, MSCI provides real restate reporting, market data, benchmarking, and analytics to investors and real estate managers.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.